Identification of Cell‐Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis
Arthritis & Rheumatology · 2023-07 · 75 (7) · 1088-1097
DOI: 10.1002/art.42464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 09.05.2023. Verfasst von Cameron Adams und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, University of California, Berkeley. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Objective
We undertook this study to estimate changes in cell‐specific DNA methylation (DNAm) associated with methotrexate (MTX) response using whole blood samples collected from rheumatoid arthritis (RA) patients before and after initiation of MTX treatment.
Methods
Patients included in this study were from the Rheumatoid Arthritis Medication Study (n = 66) and the University of California San Francisco Rheumatoid Arthritis study (n = 11). All patients met the American College of Rheumatology RA classification criteria. Blood samples were collected at baseline and following treatment. Disease Activity Scores in 28 joints using the C‐reactive protein level were collected at baseline and after 3–6 months of treatment with MTX. Methylation profiles were generated using the Illumina Infinium HumanMethylation450 and MethylationEPIC v1.0 BeadChip arrays using DNA from whole blood. MTX response was defined using the EULAR response criteria (responders showed good/moderate response; nonresponders showed no response). Differentially methylated positions were identified using the Limma software package and Tensor Composition Analysis, which is a method for identifying cell‐specific differential DNAm at the CpG level from tissue‐level (“bulk”) data. Differentially methylated regions were identified using Comb‐p software.
Results
We found evidence of differential global methylation between treatment response groups. Further, we found patterns of cell‐specific differential global methylation associated with MTX response. After correction for multiple testing, 1 differentially methylated position was associated with differential DNAm between responders and nonresponders at baseline in CD4+ T cells, CD8+ T cells, and natural killer cells. Thirty‐nine cell‐specific differentially methylated regions associated with MTX treatment response were identified. There were no significant findings in analyses of whole blood samples.
Conclusion
We identified cell‐specific changes in DNAm that were associated with MTX treatment response in RA patients. Future studies of DNAm and MTX treatment response should include measurements of DNAm from sorted cells. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Public Health, University of California, Berkeley.
- Centre of Genetics and Genomics Versus Arthritis, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.
- Centre of Genetics and Genomics Versus Arthritis, Manchester Academic Health Sciences Centre, NIHR Manchester BRC, Manchester University Foundation Trust, The University of Manchester, Manchester, UK.
- NIHR Manchester BRC, Manchester University Foundation Trust, and Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, Manchester Academic Health Sciences Centre, The Univers…
- University of California, San Francisco.
- National Human Genome Research Institute, NIH, Bethesda, Maryland.
ORCID-Profile: Cameron Adams, Lisa F Barcellos
Förderung
- NINDS NIH HHS
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of Neurological Disorders and Stroke
- Rheumatology Research Foundation
- Versus Arthritis
Zitieren
APA
Adams, C., Nair, N., Plant, D., Verstappen, S. M. M., Quach, H. L., Quach, D. L., Carvidi, A., Nititham, J., Nakamura, M., Graf, J., Barton, A., Criswell, L. A., & Barcellos, L. F. (2023). Identification of Cell‐Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis. Arthritis & Rheumatology, 75(7), 1088-1097. https://doi.org/10.1002/art.42464
Vancouver
Adams C, Nair N, Plant D, Verstappen SMM, Quach HL, Quach DL, et al. Identification of Cell‐Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis. Arthritis & Rheumatology. 2023;75(7):1088-1097. doi:10.1002/art.42464
BibTeX
@article{Adams2023,
author = {Adams, Cameron and Nair, Nisha and Plant, Darren and Verstappen, Suzanne M M and Quach, Hong L and Quach, Diana L and Carvidi, Alex and Nititham, Joanne and Nakamura, Mary and Graf, Jonathan and Barton, Anne and Criswell, Lindsey A and Barcellos, Lisa F},
title = {Identification of Cell‐Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis},
journal = {Arthritis & Rheumatology},
year = {2023},
volume = {75},
number = {7},
pages = {1088--1097},
doi = {10.1002/art.42464}
}
EUVIMED